Showing results (121-130 of 138) with videos related to
Sort By:
Pageof 14
Blood|November 1, 1984
Effects of monoclonal antibody therapy in patients with chronic lymphocytic leukemiaK A Foon, R W Schroff, P A Bunn, et al.The American Journal of Medicine|March 1, 1986
Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia. Therapeutic and immunologic resultsK A Foon, A E Maluish, P G Abrams, et al.Hybridoma|January 1, 1985
The generation of stable human T-cell hybridomas which constitutively produce interleukin-2 and chemotactic factorK A Foon, J L Rossio, R W Schroff, et al.Cancer Research|November 15, 1987
Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosisH C Stevenson, A M Keenan, C Woodhouse, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 1987
Indium-111 T101 monoclonal antibody is superior to iodine-131 T101 in imaging of cutaneous T-cell lymphomaJ A Carrasquillo, J L Mulshine, P A Bunn, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 1988
Effect of antibody dose on the imaging and biodistribution of indium-111 9.2.27 anti-melanoma monoclonal antibodyJ A Carrasquillo, P G Abrams, R W Schroff, et al.Cancer Research|May 1, 1988
Localization and imaging with radioiodine-labeled monoclonal antibodies in a xenogeneic tumor model for human B-cell lymphomaD J Buchsbaum, J A Sinkule, M S Stites, et al.Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.Cancer Research|November 15, 1987
Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphomaA M Keenan, J N Weinstein, J A Carrasquillo, et al.Cancer Research|September 1, 1983
Localization of 111In- and 125I-labeled monoclonal antibody in guinea pigs bearing line 10 hepatocarcinoma tumorsM I Bernhard, K M Hwang, K A Foon, et al.Pageof 14